The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

Omnia Technologies, an automation, bottling and packaging technologies platform created by Investindustrial for the beverage and pharmaceutical sectors, has announced two new acquisitions with an approximate combined turnover of €400 million. The acquisitions include F&B technology company, TMCI Padovan, and Omega, a sales engineering company with a focus on technical support and service and a long-standing partner of Omnia Technologies in the Americas. TMCI Padovan has four production plants, 230 employees, and a turnover of approximately €65 million, achieved across 90 countries through its four divisions: Easybräu-Velo, specialising in industrial and craft beer production plants; Chemtech, active in manufacturing plants for gelatin, margarine and food products; Padovan, focused on designing solutions for the wine sector; SAP-Blendtech, a division dedicated to designing machinery and plants for fruit juice and soft drink production; and IFBTECH, dedicated to the dairy segment and the production of plant-based drinks. The acquisition of TMCI Padovan will support Omnia Technologies position in the F&B industry and expand its overall presence in international markets. Following the acquisitions, the company is expected to have a consolidated turnover of approximately €400 million, with 17 production sites and 1,400 employees. Andrea Stolfa, CEO of Omnia Technologies, said: "These acquisitions are a fundamental step in our growth path. TMCI Padovan is a company with over 100 years’ history and a unique portfolio of knowledge and clients, while Omega synergically complements our offering and improves our service. As a result, we will be able to strengthen Omnia Technologies' presence in the machinery for the food and beverage industry and to further expand our offering in the processing and bottling segments." Omnia Technologies was advised on the TMCI Padovan acquisition by Banca Finint, BonelliErede, PwC, WSP Italia and Willis Towers Watson.